Please login to the form below

Not currently logged in
Email:
Password:

Edelman UK appoints Kate Hawker as healthcare MD

She joins the communications agency from Burson-Marsteller

Kate HawkerGlobal communications firm, Edelman has appointed Kate Hawker as healthcare managing director

She has over 25 years’ experience working within the biopharmaceutical sector, covering a variety of therapeutic areas for global, EMEA and UK clients that have included AstraZeneca, GlaxoSmithKline and Novartis.

She said: “Edelman boasts a prestigious health team with an enviable client roster and vibrant team culture.

“There remains a relentless ambition to innovate and to offer ‘best in class’ creative approaches to deliver great work for our clients.

“There is more to achieve, and I am thrilled to be joining at this time.”

Formerly healthcare chair at Burson-Marsteller, Hawker has a background in healthcare communications serving the likes of InforMed, and Fleishman-Hillard, and founding in 2000 medical communications agency The Remedy.

Matt Hurst, chief operating officer for Edelman UK, said: “Kate’s ability to develop and execute effective campaigns creatively within regulatory and legal frameworks is impressive.

“Her skills and leadership experience will be very valuable to our clients as we continue to build integrated programmes.”

16th June 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics